Anal Fissure Clinical Trial
Official title:
Étude Monocentrique de faisabilité d'un Nouveau Dispositif Pour le Traitement de la Fissure Anale Par Toxine Botulique (FR) Monocentric Feasibility Study for a New Medical Device for the Treatment of Anal Fissure With Botulinum Toxin (EN)
Monocentric feasibility study for a new device for the treatment of anal fissure with botulinum toxin.
Anal fissure is a common anal disease. This is a longitudinal tear in the distal part of the anal canal. The fissure provokes a spasm of the internal anal sphincter and as such pain and eventually bleeding. There are currently 3 different treatments. All available treatments tend to relax the anal sphincter, which reduces pain and promotes fissure healing. The first treatment consists in the local application of cream into the anal canal. The second option is the injection of botulinum toxin into the internal or external anal sphincter. Finally the third option is a surgical intervention, most frequently a lateral sphincterotomy. Although the usefulness of botulinum toxin to treat anal fissure has been demonstrated, the results vary. This is most likely largely due to the fact that there is no standardized way to inject botulinum toxin and that there is a significant learning curve. In addition, the gesture is not without risk for the operator. The objective of the study is to assess the feasibility of injecting botulinum toxin into the anal canal with a new medical device for patients with anal fissure. The trial is a mono-centric pilot study conducted on 4 patients. The study is open, prospective and all patients will be treated with the botulinum toxin injected using the new medical device. The device (single-use) under investigation and the botulinum toxin will be made available free of charge to the patient. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06216223 -
Laser Versus Surgery in Anal Diseases in Inflammatory Bowel Patients
|
N/A | |
Not yet recruiting |
NCT05405634 -
Microbiota in Chronic Anal Fissure and Its Association With Prognosis
|
||
Completed |
NCT05736926 -
Anal Fissure Among Survivors of COVID-19 Virus Infection.
|
||
Enrolling by invitation |
NCT00980369 -
The Importance of Lateral Internal Sphincterotomy Incision: Parallel or Vertical
|
N/A | |
Completed |
NCT05616455 -
Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chronic Anal Fissure: a Randomised Controlled Trial
|
Phase 4 | |
Completed |
NCT03345511 -
Ultrasound Guided Caudal Block for Benign Anal Surgery
|
N/A | |
Completed |
NCT05341180 -
Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial
|
Phase 2/Phase 3 | |
Completed |
NCT03528772 -
Topical Minoxidil Versus Topical Glyceryl Trinitrate in Treatment of Chronic Anal Fissure
|
N/A | |
Active, not recruiting |
NCT04428697 -
Sungurtekin Technique vs. Closed Lateral Internal Sphincterotomy Technique
|
N/A | |
Terminated |
NCT02023047 -
An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01920074 -
Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure
|
Phase 4 | |
Recruiting |
NCT01039051 -
Diet and Lifestyle Intervention Study in Postpartum Women in China
|
Phase 2/Phase 3 | |
Completed |
NCT00210444 -
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
|
Phase 2 | |
Completed |
NCT00827736 -
Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure
|
Phase 4 | |
Withdrawn |
NCT02667535 -
PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure
|
Phase 1 | |
Not yet recruiting |
NCT06049524 -
Could Preoperative Assessment of Physical and Psychological Status Help Predict Pain After Anorectal Surgery?
|
||
Not yet recruiting |
NCT05709717 -
Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
|
||
Completed |
NCT05038605 -
Topical vs Oral Metronidazole After Benign Anorectal Surgery
|
N/A | |
Not yet recruiting |
NCT03780998 -
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
|
||
Completed |
NCT03426449 -
Posterolateral Versus Lateral Internal Anal Sphincterotomy for Chronic Anal Fissure
|
N/A |